Discovery and development of potent and selective dual NUAK/MARK inhibitors as Hippo pathway modulators for the treatment of cancer

Authors: David Smil, Yong Liu, Tao Xin et al.
Publication: European Journal of Medicinal Chemistry
Published: Jul 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

A Simplified Approach to Evaluate Retinal Blue Light Hazard Using the Correlated Color Temperature of LED Light Sources

Farough Mohammadian, Ahmad Mehri et al. - Oct 2121

Read More
The Development of Loyalty with Online Services Customers

Apostolos Giovanis - Jan 2117

Read More
Corporate Social Responsibility: A marketing tool and/or a factor for the promotion of sustainable development for companies? An empirical examination of listed companies in the Athens Stock Exchange

Olga Helen Astara, Roldo Mitoula et al. - Apr 2115

Read More
Knowledge discovery and computerized reasoning to assist tourist destination marketing

George Stalidis, Dimitrios Karapistolis - Dec 2114

Read More
Peri-Urban Food Futures: Opportunities and Challenges to Reconfiguring Sustainable Local Agri-food Value Chains on the Sunshine Coast, Australia

Brian Stockwell, Elaine Bradley et al. - Nov 2103

Read More